On January 13 to 17 the “Train the trainer” event took place in Hurghada (Egypt), in which oncological surgeon experts in PIPAC applied to the treatment of peritoneal carcinomatosis, gathered to see the latest updates on this treatment technique of advanced chemotherapy.
PIPAC is a chemotherapy treatment that is applied as an aerosol inside the patient’s abdominal cavity. It is used in patients diagnosed with peritoneal carcinomatosis and involves making two small incisions and introducing a chemotherapy nebulizer into the abdomen through laparoscopy. Through this device, chemotherapy is spread in the form of “fine rain” directly on the area affected by the tumor and the entire peritoneum.
Historically, peritoneal carcinomatosis had been considered a terminal phase of cancer, but for a decade, it has been considered a localized cancer and patients who do not respond to conventional chemotherapy have this option. The first application was made in 2011 at the Hospital of Bielefeld Evangelical, by Dr. Marc A. Reymond, and currently the medical community still considers it a technique in the testing phase, with very encouraging results, having already demonstrated that it increases the quality of the patient’s life by controlling the symptoms.
The “Train the trainer” event was organized by Dr. Reymond, a German oncological surgeon who focuses his research activities on the study of the pleura and peritoneum, with the publication of more than 120 papers throughout his career. He is responsible for Oncological Surgery and the PIPAC unit of the University of Ruhr Bochum. The event was also co-organized by the International Society for the Study of Pleura and Peritoneum (ISSPP).
During the day, topics such as criteria of indications, protocols, safety and application of the PIPAC chemotherapy treatment to patients with peritoneal carcinomatosis were unified. The objective of the meeting was twofold: on the one hand, to establish the same line of work to be followed by all oncological surgeons who apply PIPAC, in order to obtain scientific results about the treatment. On the other hand, establish the bases for the organization of training (about 6 a year) throughout the world, for all those surgeons who want to be certified through the necessary training courses.
Quénet Torrent Institute, led by Dr. Juan José Torrent, was present at this global reference meeting in the PIPAC area. “International collaborations have been created (among professionals from European, Asian and Middle Eastern countries), which will help to advance much faster in solutions for patients with peritoneal carcinomatosis,” says Dr. Torrent. “The key is that we share our professional experience and the clinical trials carried out jointly,” explains the oncological surgeon.